TA
ABBV icon

TCM Advisors’s AbbVie ABBV Stock Holding History

TCM Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 40
2026
Q1 		– Hold
0
– – – 51
2025
Q4 		– Hold
0
– – – 45
2025
Q3 		– Hold
0
– – – 43
2025
Q2 		– Hold
0
– – – 51
2024
Q4 		– Hold
0
– – – 23
2024
Q3 		– Hold
0
– – – 17
2024
Q2 		– Hold
0
– – – 16
2024
Q1 		– Hold
0
– – – 20
2023
Q4 		– Hold
0
– – – 24
2023
Q3 		– Hold
0
– – – 24
2023
Q2 		– Hold
0
– – – 40
2023
Q1 		– Hold
0
– – – 20
2022
Q4 		– Hold
0
– – – 14
2022
Q3 		– Hold
0
– – – 17
2022
Q2 		– Hold
0
– – – 13
2022
Q1 		– Sell
-11,000
Closed -$1.6M – 14
2021
Q4 		$1.5M Buy
+11,000
New +$1.3M 1.33% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TCM Advisors's ABBV Position: Q2 2026 in Review

TCM Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 0 shares worth $780K. The position accounts for 0.06% of the portfolio, ranked #40.

TCM Advisors first reported a position in ABBV in Q4 2021 and has held it in 1 quarter since. The position peaked at $1.5M in Q4 2021. 4,244 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TCM Advisors held 0 shares of AbbVie worth $780K as of Q2 2026.
  • TCM Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.06% of TCM Advisors's portfolio in Q2 2026, its #40 holding.
  • TCM Advisors first reported a position in AbbVie in Q4 2021 and has held it in 1 quarter since.
  • TCM Advisors's AbbVie position peaked at $1.5M in Q4 2021.
  • 4,244 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TCM Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.